Acadian Asset Management
DERM icon

Acadian Asset Management’s Journey Medical DERM Stock Holding History

Acadian Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,772
Closed -$28K – 1693
2025
Q1 		$28K Sell
4,772
-12,585
-73% -$61.9K ﹤0.01% 1503
2024
Q4 		$67K Sell
17,357
-24,353
-58% -$133K ﹤0.01% 1413
2024
Q3 		$235K Sell
41,710
-52,694
-56% -$271K ﹤0.01% 1305
2024
Q2 		$531K Sell
94,404
-128,259
-58% -$528K ﹤0.01% 1178
2024
Q1 		$817K Buy
222,663
+194,389
+688% +$846K ﹤0.01% 895
2023
Q4 		$162K Buy
+28,274
New +$126K ﹤0.01% 1275

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Acadian Asset Management's DERM Position: Q2 2025 in Review

Acadian Asset Management sold out of Journey Medical (DERM) in Q2 2025, closing a stake of 4,772 shares — an estimated $28K sold.

Acadian Asset Management first reported a position in DERM in Q4 2023 and held it in 6 quarters. The position peaked at $817K in Q1 2024. 56 funds tracked by Wall St. Rank hold DERM as of Q2 2025.

  • Acadian Asset Management reported no remaining Journey Medical position as of Q2 2025 after selling out during the quarter.
  • Acadian Asset Management sold 4,772 Journey Medical shares in Q2 2025, an estimated $28K.
  • Acadian Asset Management first reported a position in Journey Medical in Q4 2023 and held it in 6 quarters.
  • Acadian Asset Management's Journey Medical position peaked at $817K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Journey Medical as of Q2 2025.

Based on Acadian Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.